Archer Materials Limited (AXE.XA)
| Previous close | 0.4650 |
| Open | 0.4550 |
| Bid | 0.0000 x N/A |
| Ask | 0.4650 x N/A |
| Day's range | 0.4550 - 0.4700 |
| 52-week range | 0.3000 - 0.7450 |
| Volume | |
| Avg. volume | 259,948 |
| Market cap | N/A |
| Beta (5Y monthly) | 1.28 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Archer and EPFL Co-Develop a Single Chip Integrated Pulsed Electron Spin Resonance Microsystem
ADELAIDE, Australia, March 25, 2024--Archer Materials Limited ("Archer", the "Company", "ASX: AXE"), a semiconductor company advancing the quantum technology and medical diagnostics industries, has built a single chip integrated pulsed electron spin resonance ("p-ESR") microsystem, with its research partner École Polytechnique Fédérale de Lausanne ("EPFL") in Switzerland.
- Business Wire
Archer Miniaturises Biochip gFET Chip Design
ADELAIDE, Australia, March 15, 2024--Archer Materials Limited ("Archer", the "Company", "ASX: AXE"), a semiconductor company advancing the quantum computing and medical diagnostics industries, has designed a miniaturised version of its Biochip graphene field effect transistor ("gFET") chip for fabrication at a commercial foundry.
- GlobeNewswire
Archer Demonstrates Multiplexing Readout for Its Advanced Biochip gFET
Highlights Archer Materials has demonstrated multiplexing readout for its Biochip by integrating its advanced gFET sensors with newly developed hardware and software that analyse multiple liquid samples on a chip at once.Archer will apply the single-chip multiplexing capability to biologically relevant molecules, which will potentially enable end-users to detect multiple diseases from one single chip.The Biochip designs and devices form the basis of intellectual property that is 100% owned by Ar
